Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer
Top Cited Papers
- 31 October 2012
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 127 (1), 5-10
- https://doi.org/10.1016/j.ygyno.2012.06.035
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006British Journal of Cancer, 2011
- Incidence of nodal metastasis in endometrioid endometrial cancer risk groups: A Gynecologic Oncology Group multicenter reviewGynecologic Oncology, 2011
- Role of Systematic Lymphadenectomy and Adjuvant Radiation in Early-Stage Endometrioid Uterine CancerAnnals of Surgical Oncology, 2010
- Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised studyThe Lancet, 2009
- Prospective assessment of lymphatic dissemination in endometrial cancer: A paradigm shift in surgical stagingGynecologic Oncology, 2008
- The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histologyInternational Journal of Gynecologic Cancer, 2008
- A Prospective Blinded Evaluation of the Accuracy of Frozen Section for the Surgical Management of Endometrial CancerObstetrics & Gynecology, 2006
- Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer1Journal of the American College of Surgeons, 2004
- Classification of Surgical ComplicationsAnnals of Surgery, 2004
- Sequence Effects, Health Profiles, and the QALY ModelMedical Decision Making, 1998